RoyNissimAlcalayMD

Hospital/Neurohospitalist

Assistant professor of neurology at the Taub Institute and the program director of the Movement Disorders Fellowship at the Columbia University Medical Center

Join to view full profile

Dr. Alcalay is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Alcalay's full profile

Already have an account?

Office
710 W 168th St
Rm 305
New York, NY 10032
Phone+1 212-305-1303

Fax+1 212-305-1304

Education & Training

Massachusetts General HospitalInternship, Internal Medicine, 2003 - 2004
Tel Aviv University SacklerClass of 2003

Certifications & Licensure

FL State Medical License 2021 - Present
NY State Medical License 2007 - 2026
American Board of Psychiatry and Neurology Neurology

Clinical Trials

Fox Investigation for New Discovery of Biomarkers Start of enrollment: 2012 Oct 01
Completed
Antigen Presentation and Lymphocyte Response in Parkinson's Disease Start of enrollment: 2015 Feb 01
Completed
PDGeneration: Mapping the Future of Parkinson's Disease Start of enrollment: 2019 Aug 15
Active, not recruiting
Not Applicable
Autoimmune Features of Neurodegenerative Disorders Start of enrollment: 2019 May 01
Recruiting
Join now to see all

Publications & Presentations

PubMed

Radiological markers of CSF α-synuclein aggregation in Parkinson's disease patients.
Amgad Droby, Avital Yoffe-Vasiliev, Daniel Atias, Kyle B Fraser, Omar S Mabrouk
NPJ Parkinson's Disease. 2025-01-03
Correction: The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminer...
Jace Jones-Tabah, Kathy He, Nathan Karpilovsky, Konstantin Senkevich, Ghislaine Deyab
Molecular Neurodegeneration. 2024-12-18
PINK1 is a target of T cell responses in Parkinson's disease.
Gregory P Williams, Antoine Freuchet, Tanner Michaelis, April Frazier, Ngan K Tran
The Journal of Clinical Investigation. 2024-12-17

Journal Articles

Case Report Corticobasal Syndrome in a Man with Gaucher Disease Type 1: Expansion of the Understanding of the Neurological Spectrum
Priya S Kishnani, Jeffrey W Cooney, Roy N Alcalay, Stephanie M DeArmey, ScienceDirect
Common and Rare GCH1 Variants Are Associated with Parkinson's Disease
Roy N. Alcalay, Stanley Fahn, Cheryl Waters, ScienceDirect

Press Mentions

Published Research from the Parkinson’s Foundation Shows Genetic Variants Are More Common in People with Parkinson’s Disease Than Originally ThoughtJuly 29th, 2024
NeuroSense Therapeutics Reports Positive Preliminary Results in Parkinson's Biomarker StudyMay 2nd, 2023
Study Identifies Pandemic-Related Stressor in Parkinson’s DiseaseSeptember 23rd, 2021
Join now to see all